DALKYLA Trademark

Trademark Overview

On Monday, June 11, 2012, a trademark application was filed for DALKYLA with the United States Patent and Trademark Office. The USPTO has given the DALKYLA trademark a serial number of 85648903. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 11, 2014. This trademark is owned by Delcath Systems, Inc.. The DALKYLA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical products for the treatment of cancer
dalkyla

General Information

Serial Number85648903
Word MarkDALKYLA
Filing DateMonday, June 11, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 11, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2012

Trademark Statements

Goods and Servicespharmaceutical products for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 20, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDelcath Systems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10019
Party NameDelcath Systems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10019

Trademark Events

Event DateEvent Description
Monday, August 11, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 11, 2014ABANDONMENT - NO USE STATEMENT FILED
Wednesday, April 2, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 31, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 31, 2014TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 12, 2014EXTENSION 2 GRANTED
Tuesday, January 7, 2014EXTENSION 2 FILED
Friday, February 7, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 7, 2014TEAS EXTENSION RECEIVED
Wednesday, June 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 10, 2013EXTENSION 1 GRANTED
Monday, June 10, 2013EXTENSION 1 FILED
Monday, June 10, 2013TEAS EXTENSION RECEIVED
Tuesday, January 8, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 13, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 13, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 1, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 25, 2012ASSIGNED TO EXAMINER
Wednesday, June 20, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 14, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

dalkyla cancer treatment products pharmaceutical